Generative AI and LLMs in Clinical Oncology Review
- •Researchers published a comprehensive review of generative AI in clinical oncology in MedComm on June 23, 2026.
- •The review examines LLMs, GANs, diffusion models, and multimodal foundation models for integrated cancer care.
- •Key focus areas include clinical decision support, data privacy, and the potential for future human-AI collaborative workflows.
A study published in MedComm on June 23, 2026, explores the integration of generative artificial intelligence and large language models (LLMs) within clinical oncology. Researchers Yunfang Yu, Zhenhui Zhao, Zehua Wang, and colleagues review how these models synthesize heterogeneous data sources, such as electronic health records, medical imaging, pathology, genomics, and clinical text. The analysis covers methodological foundations for applications including cancer diagnosis, prognosis, treatment planning, and clinical trial optimization.
The authors address significant technical challenges, specifically focusing on multimodal data integration, synthetic data generation, and clinical reasoning. The report evaluates current limitations regarding interpretability, reliability, data privacy, and regulatory governance. Emerging agent-based architectures and human-AI collaborative workflows are noted as potential future directions to advance clinically deployable, trustworthy oncology systems.